Edwards Lifesciences exec exercises performance stock units
Edwards Lifesciences Corp executive Daveen Chopra reported routine equity compensation activity involving performance-based restricted stock units.
Rhea-AI Filing Summary
Edwards Lifesciences Corp executive Daveen Chopra reported routine equity compensation activity involving performance-based restricted stock units. Chopra exercised performance rights covering 13,583 shares of common stock, linked to awards granted on May 11, 2023 with three-year performance vesting.
In connection with vesting, 7,538 shares of common stock were disposed of to cover tax obligations at a price of $79.96 per share, rather than through an open-market sale. Following these transactions, Chopra holds 45,824 shares of Edwards Lifesciences common stock directly.
The board’s Compensation and Governance Committee previously determined that 167.70% of the target number of performance-based units would vest as of May 11, 2026, and this Form 4 reflects the resulting share delivery and tax-withholding disposition.
Positive
- None.
Negative
- None.
Insider Trade Summary
13,583 shares exercised/converted
Exercise
3 txns
Insider
Chopra Daveen
Role
CVP, TMTT & Surgical
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Rights | 13,583 | $0.00 | $0.00 |
| Exercise | Common Stock | 13,583 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 7,538 | $79.96 | $603K |
Holdings After Transaction:
Performance Rights — 0 contracts (Direct);
Common Stock — 45,824 shares (Direct)
Footnotes (2)
- F1. On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4.
- F2. These Performance Rights expire on May 10, 2030.
Key Figures
Performance shares exercised: 13,583 shares
Shares withheld for taxes: 7,538 shares
Tax-withholding price: $79.96 per share
+3 more
6 metrics
Performance shares exercised
13,583 shares
Common stock from performance rights exercised on May 11, 2026
Shares withheld for taxes
7,538 shares
Tax-withholding disposition at $79.96 per share
Tax-withholding price
$79.96 per share
Price used for 7,538-share tax payment in stock
Shares held after transactions
45,824 shares
Direct common stock ownership following Form 4 transactions
Performance vesting factor
167.70%
Portion of target performance-based units determined to vest
Performance rights expiration
May 10, 2030
Expiration date of the performance rights award
Key Terms
Performance Rights, restricted stock units, performance-based vesting requirements, tax-withholding disposition, +1 more
5 terms
Performance Rights financial
"These Performance Rights expire on May 10, 2030."
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
restricted stock units financial
"granted a target number of shares covered by restricted stock units with performance-based vesting requirements"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
performance-based vesting requirements financial
"restricted stock units with performance-based vesting requirements over a three-year performance period"
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative exercise/conversion financial
"Exercise or conversion of derivative security"
FAQ
What insider transactions did Edwards Lifesciences (EW) report for Daveen Chopra?
Edwards Lifesciences reported that executive Daveen Chopra exercised performance rights for 13,583 shares of common stock and had 7,538 shares withheld to cover taxes. These actions reflect routine equity compensation vesting, not open-market buying or selling.
What performance award vested for Edwards Lifesciences (EW) executive Daveen Chopra?
Chopra’s award was a grant of restricted stock units with performance-based vesting over three years. The board’s Compensation and Governance Committee determined that 167.70% of the target units vested as of May 11, 2026, resulting in 13,583 shares delivered.
Was the Edwards Lifesciences (EW) Form 4 for Daveen Chopra an open-market stock sale?
No. The filing shows a tax-withholding disposition of 7,538 shares at $79.96 per share to satisfy tax obligations on vested performance rights, rather than a discretionary open-market sale of shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
